GLP-1 adoption weighing on packaged snack sales
Rising GLP-1 drug adoption is creating a structural volume drag on packaged sweet snack manufacturers.
Sign in to read the full idea
The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day. No card required.